Changes in indications for outpatient percutaneous liver biopsy over 5 years: from hepatitis C to fatty liver disease

Gastroenterología y Hepatología (English Edition) - Tập 45 - Trang 579-584 - 2022
Marlone Cunha-Silva1, Luíza D. Torres1, Mariana F. Fernandes1, Tirzah de M. Lopes Secundo1, Marina C.G. Moreira1, Ademar Yamanaka1, Leonardo T. Monici1, Larissa B. Eloy da Costa2, Daniel F. Mazo1,3, Tiago Sevá-Pereira1
1Division of Gastroenterology (Gastrocentro), University of Campinas (Unicamp), Campinas, Brazil
2Department of Pathology, University of Campinas/UNICAMP, Campinas, Brazil
3Division of Clinical Gastroenterology and Hepatology, Department of Gastroenterology, University of Sao Paulo School of Medicine (FMUSP), Sao Paulo, Brazil

Tài liệu tham khảo

Tapper, 2017, Use of liver imaging and biopsy in clinical practice, N Engl J Med, 377, 2296, 10.1056/NEJMra1610570 Younossi, 1998, Ultrasound-guided liver biopsy for parenchymal liver disease: and economic analysis, Dig Dis Sci, 43, 46, 10.1023/A:1018815802500 Lindor, 1996, The role of ultrasonography and automatic-needle biopsy in outpatient percutaneous liver biopsy, Hepatology, 23, 1079, 10.1002/hep.510230522 Rockey, 2009, Liver biopsy, Hepatology, 49, 1017, 10.1002/hep.22742 Myers, 2008, Utilization rates, complications and costs of percutaneous liver biopsy: a population-based study including 4275 biopsies, Liver Int, 28, 705, 10.1111/j.1478-3231.2008.01691.x DiTeodoro, 2013, Ultrasound marking by gastroenterologists prior to percutaneous liver biopsy removes the need for a separate radiological evaluation, Hepatogastroenterology, 60, 821 Heyens, 2021, Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment, Front Med (Lausanne), 8, 615978, 10.3389/fmed.2021.615978 Filingeri, 2015, Complications and risk factors of a large series of percutaneous liver biopsies in patients with liver transplantation or liver disease, Eur Rev Med Pharmacol Sci, 19, 1621 Parente, 2018, US-Guided percutaneous core liver biopsy: analysis of 171 cases from a single oncology service, Arq Gastroenterol, 55, 208, 10.1590/s0004-2803.201800000-55 Patel, 2018, Assessment of appropriate recovery time after liver biopsy, J Am Coll Radiol, 15, 1266, 10.1016/j.jacr.2018.04.004 Sporea, 2008, Why, who and how should perform liver biopsy in chronic liver diseases, World J Gastroenterol, 14, 3396, 10.3748/wjg.14.3396 Bravo, 2001, Liver biopsy, N Engl J Med, 344, 495, 10.1056/NEJM200102153440706 Taykar, 2017, Complications of percutaneous liver biopsy with Klatskin needles: a 36-year single-centre experience, Aliment Pharmacol Ther, 45, 744, 10.1111/apt.13939 Jarcuska, 2016, Evaluation of hepatic fibrosis – access to non-invasive methods, national practice/guidelines in Central Europe, Clin Exp Hepatol, 2, 12, 10.5114/ceh.2016.58851 Eisenberg, 2003, Prevalence and characteristics of pain induced by percutaneous liver biopsy, Anesth Analg, 96, 1392, 10.1213/01.ANE.0000060453.74744.17 Kose, 2015, Evaluation of percutaneous liver biopsy complications in patients with chronic viral hepatitis, Eur J Med, 47, 161 Filingeri, 2016, A retrospective analysis of 1011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications?, Eur Rev Med Pharmacol Sci, 20, 3609 Almeida, 2017, Clinical characteristics and complications of pediatric liver biopsy: a single centre experience, Ann Hepatol, 16, 797, 10.5604/01.3001.0010.2809 Lee, 2020, A scoring system for the diagnosis of non-alcoholic steatohepatitis from liver biopsy, J Pathol Transl Med, 54, 228, 10.4132/jptm.2020.03.07 Ballestri, 2021, Liver fibrosis biomarkers accurately exclude advanced fibrosis and are associated with higher cardiovascular risk scores in patients with NAFLD or viral chronic liver disease, Diagnostics (Basel), 11, 98, 10.3390/diagnostics11010098 Alqahtani, 2021, Changing trends in liver transplantation indications in Saudi Arabia: from hepatitis C virus infection to nonalcoholic fatty liver disease, BMC Gastroenterol, 21, 245, 10.1186/s12876-021-01828-z Van der Poorten, 2006, Twenty-year audit of percutaneous liver biopsy in a major Australian teaching hospital, Intern Med J, 36, 692, 10.1111/j.1445-5994.2006.01216.x Midia, 2019, Predictors of bleeding complications following percutaneous image-guided liver biopsy: a scoping review, Diagn Interv Radiol, 25, 71, 10.5152/dir.2018.17525 Thampanitchawong, 1999, Liver biopsy: complications and risk factors, World J Gastroenterol, 5, 301, 10.3748/wjg.v5.i4.301 Seeff, 2010, Complication rate of percutaneous liver biopsies among persons with advanced chronic liver disease in the HALT-C trial, Clin Gastroenterol Hepatol, 8, 877, 10.1016/j.cgh.2010.03.025 tenBerge, 2002, EUS-guided fine needle aspiration of the liver: indications, yield, and safety based on an international survey of 167 cases, Gastrointest Endosc, 55, 859, 10.1067/mge.2002.124557 Manolakopoulos, 2007, Ultrasound-guided liver biopsy in real life: comparison of same-day prebiopsy versus real-time ultrasound approach, J Gastroenterol Hepatol, 22, 1490, 10.1111/j.1440-1746.2007.04992.x